Australia Drug Eluting Stent Market Size & Outlook
Australia drug eluting stent market, 2018-2030 (US$M)
Related Markets
Australia drug eluting stent market highlights
- The Australia drug eluting stent market generated a revenue of USD 230.3 million in 2023 and is expected to reach USD 419.4 million by 2030.
- The Australia market is expected to grow at a CAGR of 8.9% from 2024 to 2030.
- In terms of segment, polymer-based coating was the largest revenue generating type of coating in 2023.
- Polymer-free Coating is the most lucrative type of coating segment registering the fastest growth during the forecast period.
Drug eluting stent market data book summary
| Market revenue in 2023 | USD 230.3 million |
| Market revenue in 2030 | USD 419.4 million |
| Growth rate | 8.9% (CAGR from 2023 to 2030) |
| Largest segment | Polymer-based coating |
| Fastest growing segment | Polymer-free Coating |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Polymer-based Coating, Polymer-free Coating |
| Key market players worldwide | Abbott Laboratories, Boston Scientific Corp, Terumo Corp, Medtronic PLC, Lepu Medical, Biosensors, Cook Medical, B. Braun, BIOTRONIK |
Other key industry trends
- In terms of revenue, Australia accounted for 3.0% of the global drug eluting stent market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, China drug eluting stent market is projected to lead the regional market in terms of revenue in 2030.
- India is the fastest growing regional market in Asia Pacific and is projected to reach USD 539.8 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Drug Eluting Stent Market Scope
Drug Eluting Stent Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Australia drug eluting stent market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to drug eluting stent market will help companies and investors design strategic landscapes.
Polymer-based coating was the largest segment with a revenue share of 82.59% in 2023. Horizon Databook has segmented the Australia drug eluting stent market based on polymer-based coating, polymer-free coating covering the revenue growth of each sub-segment from 2018 to 2030.
Reasons to subscribe to Australia drug eluting stent market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Australia drug eluting stent market databook
-
Our clientele includes a mix of drug eluting stent market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Australia drug eluting stent market , including forecasts for subscribers. This country databook contains high-level insights into Australia drug eluting stent market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Australia drug eluting stent market size, by type of coating, 2018-2030 (US$M)
Australia Drug Eluting Stent Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
